Andrew Goldsweig to Databases, Factual
This is a "connection" page, showing publications Andrew Goldsweig has written about Databases, Factual.
Connection Strength
1.168
-
Jhand AS, Abusnina W, Tak HJ, Ahmed A, Ismayl M, Altin SE, Sherwood MW, Alexander JH, Rao SV, Abbott JD, Carson JL, Goldsweig AM. Impact of anemia on outcomes and resource utilization in patients with myocardial infarction: A national database analysis. Int J Cardiol. 2024 Aug 01; 408:132111.
Score: 0.711
-
Goldsweig AM, Tak HJ, Chen LW, Aronow HD, Shah B, Kolte D, Desai NR, Szerlip M, Velagapudi P, Abbott JD. Relative Costs of Surgical and Transcatheter Aortic Valve Replacement and Medical Therapy. Circ Cardiovasc Interv. 2020 05; 13(5):e008681.
Score: 0.135
-
Goldsweig AM, Tak HJ, Chen LW, Aronow HD, Shah B, Kolte DS, Velagapudi P, Desai N, Szerlip M, Abbott JD. The Evolving Management of Aortic Valve Disease: 5-Year Trends in SAVR, TAVR, and Medical Therapy. Am J Cardiol. 2019 09 01; 124(5):763-771.
Score: 0.127
-
Zahid S, Din MTU, Khan MZ, Rai D, Ullah W, Sanchez-Nadales A, Elkhapery A, Khan MU, Goldsweig AM, Singla A, Fonarrow G, Balla S. Trends, Predictors, and Outcomes of 30-Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database. J Am Heart Assoc. 2022 08 16; 11(16):e024890.
Score: 0.039
-
Altin SE, Kim YG, Aronow HD, Armstrong EJ, Goldsweig AM, Dardik A, Lanksy AJ, Mena-Hurtado CI, Abbott JD. Seasonal variation in U.S. hospitalizations for chronic limb-threatening ischemia. Catheter Cardiovasc Interv. 2020 12; 96(7):1473-1480.
Score: 0.035
-
Lemor A, Basir MB, Patel K, Kolski B, Kaki A, Kapur NK, Riley R, Finley J, Goldsweig A, Aronow HD, Belford PM, Tehrani B, Truesdell AG, Lasorda D, Bharadwaj A, Hanson I, LaLonde T, Gorgis S, O'Neill W. Multivessel Versus Culprit-Vessel Percutaneous?Coronary Intervention in Cardiogenic Shock. JACC Cardiovasc Interv. 2020 05 25; 13(10):1171-1178.
Score: 0.034
-
Mahabir CA, DeFilippis EM, Aggarwal S, Bath A, Qamar A, Patel NK, Goldsweig AM, Vaduganathan M. The First 4 Years of Postmarketing Safety Surveillance Related to the MitraClip Device: A United States Food and Drug Administration MAUDE Experience. J Invasive Cardiol. 2020 05; 32(5):E130-E132.
Score: 0.034
-
Khera S, Kolte D, Gupta T, Goldsweig A, Velagapudi P, Kalra A, Tang GHL, Aronow WS, Fonarow GC, Bhatt DL, Aronow HD, Kleiman NS, Reardon M, Gordon PC, Sharaf B, Abbott JD. Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement. JAMA Cardiol. 2017 07 01; 2(7):732-741.
Score: 0.028
-
Kolte D, Khera S, Sardar MR, Gheewala N, Gupta T, Chatterjee S, Goldsweig A, Aronow WS, Fonarow GC, Bhatt DL, Greenbaum AB, Gordon PC, Sharaf B, Abbott JD. Thirty-Day Readmissions After Transcatheter Aortic Valve Replacement in the United States: Insights From the Nationwide Readmissions Database. Circ Cardiovasc Interv. 2017 01; 10(1).
Score: 0.027